Black Diamond Therapeutics Inc (BDTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 78,781 | 86,460 | 92,828 | 126,872 | 69,570 |
| Operating Income | -78,781 | -86,460 | -92,828 | -126,872 | -69,570 |
| Interest Expense | 0 | 0 | 0 | 0 | 1 |
| Other Income | 9,105 | 4,018 | 1,659 | 1,276 | 2,317 |
| Pre-tax Income | -69,676 | -82,442 | -91,169 | -125,596 | -67,254 |
| Net Income Continuous | -69,676 | -82,442 | -91,169 | -125,596 | -67,254 |
| Net Income | $-69,676 | $-82,442 | $-91,169 | $-125,596 | $-67,254 |
| EPS Basic Total Ops | -1.27 | -1.88 | -2.52 | -3.47 | -2.05 |
| EPS Basic Continuous Ops | -1.27 | -1.88 | -2.51 | -3.47 | -2.04 |
| EPS Diluted Total Ops | -1.27 | -1.88 | -2.52 | -3.47 | -2.05 |
| EPS Diluted Continuous Ops | -1.27 | -1.88 | -2.51 | -3.47 | -2.04 |
| EPS Diluted Before Non-Recurring Items | -1.27 | -1.88 | -2.52 | -3.47 | -2.05 |
| EBITDA(a) | $-78,438 | $-86,023 | $-92,320 | $-126,667 | $-69,518 |